两种提取溶剂对莲雾果实GC-MS代谢组学分析的影响

以台湾"黑珍珠"莲雾果实为实验材料,选择植物代谢组学研究中常用的两种提取溶剂对莲雾果实样品进行非靶标的代谢轮廓分析,研究两种提取溶剂对莲雾果实代谢组学分析的影响。利用气相色谱-质谱联用(GC-MS)技术对莲雾果实代谢产物进行分离鉴定,利用甲醇-水(A)法和甲醇-氯仿-水(B)法两种方法共鉴定出129个代谢产物;利用主成分分析法等比较了两种提取方法的提取效果,结果表明两种方法存在显著差异。从色谱峰总数来看,A法可检测到323个色谱峰,B法仅有251个,统计分析发现124个差异显著的代谢物质,其中有90个代谢物质的相对含量用A法提取显著高于B法提取。研究结果表明,甲醇-水溶剂提取的方法更适合于莲雾果实代谢组学的分析研究。     

两种提取溶剂对莲雾果实GC-MS代谢组学分析的影响

以台湾"黑珍珠"莲雾果实为实验材料,选择植物代谢组学研究中常用的两种提取溶剂对莲雾果实样品进行非靶标的代谢轮廓分析,研究两种提取溶剂对莲雾果实代谢组学分析的影响。利用气相色谱-质谱联用(GC-MS)技术对莲雾果实代谢产物进行分离鉴定,利用甲醇-水(A)法和甲醇-氯仿-水(B)法两种方法共鉴定出129个代谢产物;利用主成分分析法等比较了两种提取方法的提取效果,结果表明两种方法存在显著差异。从色谱峰总数来看,A法可检测到323个色谱峰,B法仅有251个,统计分析发现124个差异显著的代谢物质,其中有90个代谢物质的相对含量用A法提取显著高于B法提取。研究结果表明,甲醇-水溶剂提取的方法更适合于莲雾果实代谢组学的分析研究。     

两种提取溶剂对莲雾果实GC-MS代谢组学分析的影响

以台湾"黑珍珠"莲雾果实为实验材料,选择植物代谢组学研究中常用的两种提取溶剂对莲雾果实样品进行非靶标的代谢轮廓分析,研究两种提取溶剂对莲雾果实代谢组学分析的影响。利用气相色谱-质谱联用(GC-MS)技术对莲雾果实代谢产物进行分离鉴定,利用甲醇-水(A)法和甲醇-氯仿-水(B)法两种方法共鉴定出129个代谢产物;利用主成分分析法等比较了两种提取方法的提取效果,结果表明两种方法存在显著差异。从色谱峰总数来看,A法可检测到323个色谱峰,B法仅有251个,统计分析发现124个差异显著的代谢物质,其中有90个代谢物质的相对含量用A法提取显著高于B法提取。研究结果表明,甲醇-水溶剂提取的方法更适合于莲雾果实代谢组学的分析研究。     

两种提取溶剂对莲雾果实GC-MS代谢组学分析的影响

以台湾"黑珍珠"莲雾果实为实验材料,选择植物代谢组学研究中常用的两种提取溶剂对莲雾果实样品进行非靶标的代谢轮廓分析,研究两种提取溶剂对莲雾果实代谢组学分析的影响。利用气相色谱-质谱联用(GC-MS)技术对莲雾果实代谢产物进行分离鉴定,利用甲醇-水(A)法和甲醇-氯仿-水(B)法两种方法共鉴定出129个代谢产物;利用主成分分析法等比较了两种提取方法的提取效果,结果表明两种方法存在显著差异。从色谱峰总数来看,A法可检测到323个色谱峰,B法仅有251个,统计分析发现124个差异显著的代谢物质,其中有90个代谢物质的相对含量用A法提取显著高于B法提取。研究结果表明,甲醇-水溶剂提取的方法更适合于莲雾果实代谢组学的分析研究。     

两种提取溶剂对莲雾果实GC-MS代谢组学分析的影响

以台湾"黑珍珠"莲雾果实为实验材料,选择植物代谢组学研究中常用的两种提取溶剂对莲雾果实样品进行非靶标的代谢轮廓分析,研究两种提取溶剂对莲雾果实代谢组学分析的影响。利用气相色谱-质谱联用(GC-MS)技术对莲雾果实代谢产物进行分离鉴定,利用甲醇-水(A)法和甲醇-氯仿-水(B)法两种方法共鉴定出129个代谢产物;利用主成分分析法等比较了两种提取方法的提取效果,结果表明两种方法存在显著差异。从色谱峰总数来看,A法可检测到323个色谱峰,B法仅有251个,统计分析发现124个差异显著的代谢物质,其中有90个代谢物质的相对含量用A法提取显著高于B法提取。研究结果表明,甲醇-水溶剂提取的方法更适合于莲雾果实代谢组学的分析研究。     

两种提取溶剂对莲雾果实GC-MS代谢组学分析的影响

以台湾"黑珍珠"莲雾果实为实验材料,选择植物代谢组学研究中常用的两种提取溶剂对莲雾果实样品进行非靶标的代谢轮廓分析,研究两种提取溶剂对莲雾果实代谢组学分析的影响。利用气相色谱-质谱联用(GC-MS)技术对莲雾果实代谢产物进行分离鉴定,利用甲醇-水(A)法和甲醇-氯仿-水(B)法两种方法共鉴定出129个代谢产物;利用主成分分析法等比较了两种提取方法的提取效果,结果表明两种方法存在显著差异。从色谱峰总数来看,A法可检测到323个色谱峰,B法仅有251个,统计分析发现124个差异显著的代谢物质,其中有90个代谢物质的相对含量用A法提取显著高于B法提取。研究结果表明,甲醇-水溶剂提取的方法更适合于莲雾果实代谢组学的分析研究。     

两种提取溶剂对莲雾果实GC-MS代谢组学分析的影响

以台湾"黑珍珠"莲雾果实为实验材料,选择植物代谢组学研究中常用的两种提取溶剂对莲雾果实样品进行非靶标的代谢轮廓分析,研究两种提取溶剂对莲雾果实代谢组学分析的影响。利用气相色谱-质谱联用(GC-MS)技术对莲雾果实代谢产物进行分离鉴定,利用甲醇-水(A)法和甲醇-氯仿-水(B)法两种方法共鉴定出129个代谢产物;利用主成分分析法等比较了两种提取方法的提取效果,结果表明两种方法存在显著差异。从色谱峰总数来看,A法可检测到323个色谱峰,B法仅有251个,统计分析发现124个差异显著的代谢物质,其中有90个代谢物质的相对含量用A法提取显著高于B法提取。研究结果表明,甲醇-水溶剂提取的方法更适合于莲雾果实代谢组学的分析研究。     

两种提取溶剂对莲雾果实GC-MS代谢组学分析的影响

以台湾"黑珍珠"莲雾果实为实验材料,选择植物代谢组学研究中常用的两种提取溶剂对莲雾果实样品进行非靶标的代谢轮廓分析,研究两种提取溶剂对莲雾果实代谢组学分析的影响。利用气相色谱-质谱联用(GC-MS)技术对莲雾果实代谢产物进行分离鉴定,利用甲醇-水(A)法和甲醇-氯仿-水(B)法两种方法共鉴定出129个代谢产物;利用主成分分析法等比较了两种提取方法的提取效果,结果表明两种方法存在显著差异。从色谱峰总数来看,A法可检测到323个色谱峰,B法仅有251个,统计分析发现124个差异显著的代谢物质,其中有90个代谢物质的相对含量用A法提取显著高于B法提取。研究结果表明,甲醇-水溶剂提取的方法更适合于莲雾果实代谢组学的分析研究。     

两种提取溶剂对莲雾果实GC-MS代谢组学分析的影响

以台湾"黑珍珠"莲雾果实为实验材料,选择植物代谢组学研究中常用的两种提取溶剂对莲雾果实样品进行非靶标的代谢轮廓分析,研究两种提取溶剂对莲雾果实代谢组学分析的影响。利用气相色谱-质谱联用(GC-MS)技术对莲雾果实代谢产物进行分离鉴定,利用甲醇-水(A)法和甲醇-氯仿-水(B)法两种方法共鉴定出129个代谢产物;利用主成分分析法等比较了两种提取方法的提取效果,结果表明两种方法存在显著差异。从色谱峰总数来看,A法可检测到323个色谱峰,B法仅有251个,统计分析发现124个差异显著的代谢物质,其中有90个代谢物质的相对含量用A法提取显著高于B法提取。研究结果表明,甲醇-水溶剂提取的方法更适合于莲雾果实代谢组学的分析研究。     

两种提取溶剂对莲雾果实GC-MS代谢组学分析的影响

以台湾"黑珍珠"莲雾果实为实验材料,选择植物代谢组学研究中常用的两种提取溶剂对莲雾果实样品进行非靶标的代谢轮廓分析,研究两种提取溶剂对莲雾果实代谢组学分析的影响。利用气相色谱-质谱联用(GC-MS)技术对莲雾果实代谢产物进行分离鉴定,利用甲醇-水(A)法和甲醇-氯仿-水(B)法两种方法共鉴定出129个代谢产物;利用主成分分析法等比较了两种提取方法的提取效果,结果表明两种方法存在显著差异。从色谱峰总数来看,A法可检测到323个色谱峰,B法仅有251个,统计分析发现124个差异显著的代谢物质,其中有90个代谢物质的相对含量用A法提取显著高于B法提取。研究结果表明,甲醇-水溶剂提取的方法更适合于莲雾果实代谢组学的分析研究。     

Analysis of tamoxifen and its metabolites in human plasma by gas chromatography-mass spectrometry (GC-MS) using selected ion monitoring (SIM)

A method for the analysis of tamoxifen and its metabolites in plasma from tamoxifen treated breast cancer patients, by capillary GC-MS using selected ion monitoring has been developed. Metabolite extraction was carried out on a Sep-pak C18 cartridge and metabolite purification by selective ion exchange chromatographic steps. Satisfactory recovery of radioactive standards through the extraction and purification steps was obtained. The method was shown to be accurate and precise with precision coefficient of variation values ranging from 4.3-11% for tamoxifen and its metabolites. Tamoxifen, 4-hydroxytamoxifen, metabolite Y and N-desmethyltamoxifen were identified with certainty in patient plasma on the basis of GC relative retention times and mass spectral comparison with authentic standards; because of their low abundance in plasma cis-metabolite E and 3,4-dihydroxytamoxifen could only be tentatively identified but identical GC behaviour and a satisfactory comparison of the abundance of key fragment ions was achieved. The tamoxifen and metabolite concentration ranges (ng X ml-1) in the group of patients who received 40 or 80 ng tamoxifen for 14 days were tamoxifen, 307-745; N-desmethyltamoxifen, 185-491; 4-hydroxytamoxifen, 1.4-2.5; 3,4-dihydroxytamoxifen, 0.7-2.0; metabolite Y, 19.0-112; and metabolite E1, 0.9-2.0.     

MSClust: a tool for unsupervised mass spectra extraction of chromatography-mass spectrometry ion-wise aligned data

Mass peak alignment (ion-wise alignment) has recently become a popular method for unsupervised data analysis in untargeted metabolic profiling. Here we present MSClust-a software tool for analysis GC-MS and LC-MS datasets derived from untargeted profiling. MSClust performs data reduction using unsupervised clustering and extraction of putative metabolite mass spectra from ion-wise chromatographic alignment data. The algorithm is based on the subtractive fuzzy clustering method that allows unsupervised determination of a number of metabolites in a data set and can deal with uncertain memberships of mass peaks in overlapping mass spectra. This approach is based purely on the actual information present in the data and does not require any prior metabolite knowledge. MSClust can be applied for both GC-MS and LC-MS alignment data sets. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11306-011-0368-2) contains supplementary material, which is available to authorized users.     

Determination of

代谢组样品制备是代谢组学研究的基础。本文以维生素B12生产菌株苜蓿中华根瘤菌Sinorhizobium meliloti 320为研究对象,通过检测细胞损伤、ATP泄漏、代谢物回收效率以及细胞代谢淬灭效率综合评价细胞淬灭方法,同时对5种提取试剂的提取效率进行比较优化胞内代谢物的提取方法。最终获得苜蓿中华根瘤菌S.meliloti 320的胞内代谢组学样品制备较佳条件:即-20℃40%甲醇淬灭细胞,过滤收集淬灭细胞,甲醇/乙腈/水(体积比为2∶2∶2,外加0.1%的甲酸)与50%甲醇相结合提取胞内代谢物。实验结果显示-20℃的40%甲醇(通过过滤收集细胞)对细胞膜的损伤较小,且细胞代谢淬灭效率和回收效率较高;甲醇/乙腈/水(体积比为2∶2∶2,外加0.1%的甲酸)与50%的甲醇对胞内代谢物的提取效率较高且有互补作用。     

苜蓿中华根瘤菌代谢组学样品制备方法的研究

代谢组样品制备是代谢组学研究的基础。本文以维生素B12生产菌株苜蓿中华根瘤菌Sinorhizobium meliloti 320为研究对象,通过检测细胞损伤、ATP泄漏、代谢物回收效率以及细胞代谢淬灭效率综合评价细胞淬灭方法,同时对5种提取试剂的提取效率进行比较优化胞内代谢物的提取方法。最终获得苜蓿中华根瘤菌S.meliloti 320的胞内代谢组学样品制备较佳条件:即-20℃40%甲醇淬灭细胞,过滤收集淬灭细胞,甲醇/乙腈/水(体积比为2∶2∶2,外加0.1%的甲酸)与50%甲醇相结合提取胞内代谢物。实验结果显示-20℃的40%甲醇(通过过滤收集细胞)对细胞膜的损伤较小,且细胞代谢淬灭效率和回收效率较高;甲醇/乙腈/水(体积比为2∶2∶2,外加0.1%的甲酸)与50%的甲醇对胞内代谢物的提取效率较高且有互补作用。     

High-performance liquid chromatographic analysis of sulfinpyrazone and its metabolites in biological fluids

A rapid, sensitive, and specific high-performance liquid chromatographic method is described for the quantitative analysis of sulfinpyrazone and its sulfone and p-hydroxy metabolites in plasma and urine. The method uses two different procedures for sample preparation: (1) a rapid and convenient procedure using a single extraction with 1-chlorobutane and subsequent back-extraction into sodium hydroxide solution for the analysis of sulfinpyrazone and its sulfone metabolite, and (2) a more time consuming procedure using triple extraction with ethylene dichloride, a buffer wash, and back extraction into the base for the additional analysis of the p-hydroxy metabolite. The lower limit of sensitivity for sulfinpyrazone is 50 ng/ml. Concentrations of sulfinpyrazone between 0.05 to 0.1 and 50 μg/ml were measured with an average coefficient of variation of 3.9%, ranging from 1.5 to 6.1%.     

Determination of a prostaglandin D2 antagonist and its acyl glucuronide metabolite in human plasma by high performance liquid chromatography with tandem mass spectrometric detection--a lack of MS/MS selectivity between a glucuronide conjugate and a phase I metabolite

A method for the determination of a prostaglandin D(2) receptor antagonist (I, a compound being evaluated for the prevention of niacin induced flushing) and its acyl glucuronide metabolite (II) in human plasma is presented. The method utilized high performance liquid chromatography (HPLC) with tandem mass spectrometric (MS/MS) detection using an atmospheric pressure chemical ionization (APCI) interface operated in the positive ionization mode. The product ion was a radical cation generated via a homolytic bond cleavage. A chemical analog of the drug was used as internal standard (III). The acyl glucuronide metabolite (II) was detected using the same precursor-to-product ion transition used for the parent compound after chromatographic separation of I and II. Drug and metabolite were extracted using semi-automated, 96-well format solid phase extraction (SPE), and chromatography was performed using a reverse phase analytical column with an isocratic mobile phase. The chromatographic retention factor (k') of II was found to be highly sensitive to mobile phase formic acid concentration. An adjustment in mobile phase formic acid concentration improved the chromatographic separation between II and a mono-hydroxylated metabolite after an unexpected lack of MS/MS selectivity between the two molecules was observed. The dependence of retention factor on formic acid concentration (k' increased as formic acid concentration decreased) was thought to indicate polar interactions between II and the stationary phase. The stability of II in spiked human plasma was determined. The rate of hydrolysis back to parent compound was relatively low (approximately 0.1 and 0.5% per hour at room temperature and 4 degrees C, respectively) indicating that significant changes in analyte concentrations did not occur during sample processing. The concentration range of the assay was 10-2500 ng/mL for both drug and glucuronide metabolite.     

Quantitation of mitomycin C in human ocular tissues by high-performance liquid chromatography–photo-diode array detection

A chromatographic method, which can quantitate mitomycin C (MMC) along with two antiglaucoma drugs, is described. The separation of MMC, alphagan and timolol was performed on a reversed-phase C₁₈ column with water–methanol–trifluoroacetic acid (65:35:0.01, v/v) as the mobile phase. By monitoring at 360, 248 and 296 nm, the lower limits of detection for MMC, alphagan and timolol are, respectively, 1.0, 2.0 and 5.0 ng (injection amount) at three-time S/N ratio. The dynamic ranges of quantitation for the three drugs are, respectively, 1.0 ng–10.0 μg, 2.0 ng–10.0 μg and 5.0 ng–10.0 μg with linearity being larger than 0.9960. This method was applied to the determination of MMC levels in Tenon’s and trabeculum tissues of 10 glaucoma patients. MMC levels in these tissues, which were obtained from glaucoma filtering surgery, were determined following a multiple extraction with methanol. The recovery of MMC for a two-batch extraction was better than 91.2%. The reproducibility of measurement for the MMC levels in these tissues is 2.5–6.0% RSD for triplicate injections. The intra-day variation of retention times for the MMC peaks was less than 1.6% RSD (n=3). The inter-day variation of retention times for the MMC peaks was less than 4.8% RSD (n=3). MMC was detectable in three trabeculum tissues out of 10 cases (ranging from 0.8 to 25.5 ng/mg specimen), while MMC was detected in nine Tenon’s tissues out of 10 cases (ranging from 0.3 to 21.1 ng/mg specimen). The results obtained show that the method is sensitive and selective for the quantitation of MMC.     

Gas chromatographic–mass spectrometric assay for rocuronium with potential for quantifying its metabolite, 17-desacetylrocuronium, in human plasma

A rapid, sensitive and selective method has been developed for the quantification of plasma concentrations of neuromuscular blocking drug, rocuronium, using gas chromatography with mass spectrometric detection. 3-Desacetylvecuronium served as the internal standard. The method involved iodide ion pair formation and a single-step liquid–liquid extraction with dicholoromethane. This method also permits simultaneous determination of its putative metabolite, 17-desacetylrocuronium, although the high detection limit for the metabolite limits the practical application of this method in pharmacokinetic study of the metabolite. The extraction efficiency was 75% for rocuronium and 50% for 17-desacetylrocuronium. The limit of quantification was 26 ng/ml for rocuronium and 870 ng/ml for its metabolite. The assay was used successfully in a patient undergoing liver transplantation and receiving rocuronium as a constant rate infusion and in a patient undergoing general elective surgery receiving the drug as an intravenous bolus. This assay is a time-saving alternative to published gas or liquid chromatographic methods for assaying rocuronium.     

Determination of the anti-platelet-activating factor BN-50727 and metabolites in human urine by high-performance liquid chromatography using solid-phase extraction

A sensitive and selective HPLC solid-phase extraction procedure was developed for the determination of platelet-activating factor antagonist BN-50727 and its metabolites in human urine. The procedure consisted in a double solid-phase extraction of the urine samples on cyanopropyl and silica cartridges, followed by an automated solid-phase extraction of the drug and metabolites on CBA cartridges and posterior elution on-line to the chromatographic system for its separation. The method allowed quantitation in the concentration range 10–2400 ng/ml urine for both BN-50727 and the main metabolite, the O-demethylated BN-50727 product. The limit of quantitation for both compounds was 10 ng/ml. The inter-assay precision of the method, expressed as relative standard deviation, ranged from 1.9 to 4.5% for BN-50727 and from 2.5 to 9.0% for the metabolite. The accuracy, expressed as relative error, ranged from −2.4 to 4.2% and from 0.2 to 6.2%, respectively. This paper describes the validation of the analytical methodology for the determination of BN-50727 in human urine and also for its metabolites. The method has been used to follow the time course of BN-50727 and its metabolites in human urine after single-dose administration.     

Determination of octreotide and assessment of matrix effects in human plasma using ultra high performance liquid chromatography-tandem mass spectrometry

A selective UHPLC-MS/MS method for determination of the therapeutic peptide octreotide in human plasma was developed and validated. This assay used a UHPLC C(18) column with 1.7 μm particle size for efficient separation and an ion-exchange SPE for selective extraction. Octreotide and its labeled internal standard, [(13)C(6)Phe(3)] octreotide, were extracted from human plasma using a simple Oasis? WCX μElution SPE method and analyzed with a total chromatographic run time of 7.5 min. Matrix effects were studied during method development by direct monitoring of representative phospholipids. On-line removal of phospholipids using column switching and pre-column back-flushing was carried out to trap and remove any residual phospholipid matrix interferences. The UHPLC column provided baseline separation between the analyte and matrix peaks. The chromatographic conditions yielded optimal retention and excellent peak shape for both the analyte and internal standard. The assay was linear in the concentration range of 0.025-25.0 ng/ml, inter- and intra-assay precision and accuracy were within 6.1% and ±1.93%, respectively. Recovery was ～73%. Post-extraction addition experiments showed that matrix effects were less than 4%. This method for octreotide in human plasma has been validated and utilized to support of clinical pharmacokinetic studies.